File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Update on the recommendations on breast cancer screening by the cancer expert working group on cancer prevention and screening

TitleUpdate on the recommendations on breast cancer screening by the cancer expert working group on cancer prevention and screening
Authors
Issue Date2022
PublisherHong Kong Academy of Medicine Press: Open Access Journals. The Journal's web site is located at http://www.hkmj.org/
Citation
Hong Kong Medical Journal, 2022, v. 28 n. 2, p. 161-168 How to Cite?
AbstractBreast cancer (BC) is the most common cancer among women in Hong Kong. The Food and Health Bureau commissioned The University of Hong Kong (HKU) to conduct the Hong Kong Breast Cancer Study (HKBCS) with the aim of identifying relevant risk factors for BC in Hong Kong and developing a locally validated BC risk assessment tool for Hong Kong Chinese women. After consideration of the most recent international and local scientific evidence including findings of the HKBCS, the Cancer Expert Working Group on Cancer Prevention and Screening (CEWG) has reviewed and updated its BC screening recommendations. Existing recommendations were preserved for women at high risk and slightly changed for women at moderate risk. The following major updates have been made concerning recommendations for other women in the general population: • Women aged 44 to 69 with certain combinations of personalised risk factors (including presence of history of BC among first-degree relative, a prior diagnosis of benign breast disease, nulliparity and late age of first live birth, early age of menarche, high body mass index and physical inactivity) putting them at increased risk of BC are recommended to consider mammography screening every 2 years. They should discuss with their doctors on the potential benefits and harms before undergoing mammography screening. • A risk assessment tool for local women (eg, one developed by HKU) is recommended to be used for estimating the risk of developing BC with regard to the personalised risk factors described above.
Persistent Identifierhttp://hdl.handle.net/10722/312660
ISSN
2021 Impact Factor: 1.256
2020 SCImago Journal Rankings: 0.357
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorTsang, THF-
dc.contributor.authorWong, KH-
dc.contributor.authorAllen, K-
dc.contributor.authorChan, KKL-
dc.contributor.authorChan, MCM-
dc.contributor.authorChao, DVK-
dc.contributor.authorCheung, ANY-
dc.contributor.authorFan, CYM-
dc.contributor.authorHui, EP-
dc.contributor.authorIp, DKM-
dc.contributor.authorLam, KO-
dc.contributor.authorLaw, CK-
dc.contributor.authorLaw, WL-
dc.contributor.authorLoong, HHF-
dc.contributor.authorWong, KH-
dc.contributor.authorWong, MCS-
dc.contributor.authorYeung, RMW-
dc.contributor.authorYing, ACH-
dc.contributor.authorHo, RKW-
dc.date.accessioned2022-05-12T10:53:49Z-
dc.date.available2022-05-12T10:53:49Z-
dc.date.issued2022-
dc.identifier.citationHong Kong Medical Journal, 2022, v. 28 n. 2, p. 161-168-
dc.identifier.issn1024-2708-
dc.identifier.urihttp://hdl.handle.net/10722/312660-
dc.description.abstractBreast cancer (BC) is the most common cancer among women in Hong Kong. The Food and Health Bureau commissioned The University of Hong Kong (HKU) to conduct the Hong Kong Breast Cancer Study (HKBCS) with the aim of identifying relevant risk factors for BC in Hong Kong and developing a locally validated BC risk assessment tool for Hong Kong Chinese women. After consideration of the most recent international and local scientific evidence including findings of the HKBCS, the Cancer Expert Working Group on Cancer Prevention and Screening (CEWG) has reviewed and updated its BC screening recommendations. Existing recommendations were preserved for women at high risk and slightly changed for women at moderate risk. The following major updates have been made concerning recommendations for other women in the general population: • Women aged 44 to 69 with certain combinations of personalised risk factors (including presence of history of BC among first-degree relative, a prior diagnosis of benign breast disease, nulliparity and late age of first live birth, early age of menarche, high body mass index and physical inactivity) putting them at increased risk of BC are recommended to consider mammography screening every 2 years. They should discuss with their doctors on the potential benefits and harms before undergoing mammography screening. • A risk assessment tool for local women (eg, one developed by HKU) is recommended to be used for estimating the risk of developing BC with regard to the personalised risk factors described above.-
dc.languageeng-
dc.publisherHong Kong Academy of Medicine Press: Open Access Journals. The Journal's web site is located at http://www.hkmj.org/-
dc.relation.ispartofHong Kong Medical Journal-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleUpdate on the recommendations on breast cancer screening by the cancer expert working group on cancer prevention and screening-
dc.typeArticle-
dc.identifier.emailIp, DKM: dkmip@hku.hk-
dc.identifier.emailLam, KO: lamkaon@hku.hk-
dc.identifier.authorityIp, DKM=rp00256-
dc.identifier.authorityLam, KO=rp01501-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.12809/hkmj219622-
dc.identifier.pmid35400644-
dc.identifier.hkuros332994-
dc.identifier.volume28-
dc.identifier.issue2-
dc.identifier.spage161-
dc.identifier.epage168-
dc.identifier.isiWOS:000788081800001-
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats